About Mannitol
Mannitol is a white, odorless and sweet tasting sugar alcohol, which is often used as a diabetic food or a coat confectionery for the products such as gums and candies. It is also known as manna sugar or mannite. It provides similar properties of normal sugar with lower calorie contains. Moreover, mannitol is used as medication more often for minimizing the eye pressure for the glaucoma patients and it can be used as a diabetic food as it is very seldom absorbed from the intestines.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Vendors will contribute the maximum growth to Global Mannitol market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Cargill Incorporated (United States), Roquette Freres Company (France), Ingredion Incorporated (United States), Superior Supplement Manufacturing (United States), Spectrum Chemical Manufacturing Corp. (United States), AquaPhoenix Scientific Inc. (United States), SPI Pharma (United States), Merck Group (EMD Millipore) (United States) and Lianmeng Chemical (China) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Huaxu Pharmaceutical (China), Qingdao Bright Moon Seaweed Group Co., Ltd. (China), Singsino Group Ltd. (China), Reagents Specialty Chemicals and Solutions (United States) and Carbochem Inc.(United States).
Segmentation Overview
AMA Research has segmented the market of Global Mannitol market by Type (Powder and Granular), Application (Pharmaceutical Industry, Food Industry and Other applications) and Region.
On the basis of geography, the market of Mannitol has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Catalytic Hydrogenation Technology will boost the Mannitol market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing use of Mannitol in Cardio-pulmonary Bypass, Upsurging Adoption of Low Sugar Chewable Tablets or Gums among Diabetic Patients and R&D Initiatives to Minimize Side Effects and Maximize Medicinal Applications
Market Growth Drivers:
Growing Health Awareness across the globe will upsurge the demand for (Mannitol) Low Calorie Sugars, Eccentric Properties of Mannitol such as Better Water Solubility, Minimal Sensitivity to Humidity and Used in treatment of Severe Eye issues like Glaucoma
Challenges:
Minimize the Adverse Effects of Mannitol and Maximize Productivity of Mannitol to cope up with the Fueling Demand
Restraints:
Mannitol I.V. can cause Headache, Nausea, Diarrhea, Vomiting, and Other Adverse Side Effects and Excessive Consumption can cause Laxative Effect, which might stagnate the demand
Opportunities:
Adoption of Mannitol in Analytical Chemistry and Growing usage in Food Industry
Market Leaders and their expansionary development strategies
In November 2022, Cipla Limited and its wholly owned subsidiary Cipla USA Inc., (hereafter referred to as “Cipla”), has launched of Leuprolide Acetate Injection Depot 22.5mg. The product was approved by the United States Food and Drug Administration (“US FDA”) based on a New Drug Application (NDA) submitted under the 505(b)(2) regulatory pathway.
In November 2022, Roquette, a global leader in plant-based ingredients and provider of pharmaceutical and nutraceutical excipients has launched two next-generation mannitol products for direct compression. The excipients are called PEARLITOL CR-H and PEARLITOL 200 GT and are designed to overcome unique drug formulation challenges and help manufacturers optimize direct compression processes, as well as expand into novel application areas.
The use of Mannitol in Food Industry is permitted by Food and Drug Administration which is a food additive regulations (21 CFR 180.25). In addition to this, World Health Organization's Expert Committee on Food Additives (JECFA) has reviewed the safety data and concluded that Mannitol is safe.
Key Target Audience
Mannitol Manufacturers, Mannitol Distributors and Traders, Health Care Agencies, Government Agencies, Research Organisations and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.